Ingredient

Tazarotene

Tazarotene is flagged for pregnancy, trying to conceive, breastfeeding and general use. The concern behind the strongest flag is known teratogen and fetal development.

By Team TruvaLast checked

Verdict by profile

Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.

Strongest verdict
Not Recommended
Its verdict for pregnancy, the profile this one is worst in
Profiles flagged
4 of 6
Counting avoid, high risk and medium risk
Irritancy
4 of 5
Higher means more likely to sting or redden
PregnancyAVOID

Tazarotene and pregnancy

Not Recommended

Tazarotene is a third-generation prescription retinoid used for treating acne, psoriasis, and photoaging. Like all retinoids, it is a vitamin A derivative that works by affecting gene expression to normalize skin cell production and reduce inflammation. The FDA classifies Tazarotene as Pregnancy Category X, which means studies have demonstrated fetal risk and the risks clearly outweigh any potential benefits. Oral retinoids are known teratogens that cause severe birth defects including craniofacial, cardiac, thymic, and central nervous system malformations. While topical absorption is lower than oral formulations, case reports have documented birth defects associated with topical tazarotene use during pregnancy. ACOG explicitly states that all retinoids, including topical formulations like tazarotene, should be avoided throughout pregnancy. According to FDA labeling, tazarotene is contraindicated in women who are or may become pregnant. Prescribing information requires that women of childbearing potential have a negative pregnancy test before starting treatment and use effective contraception during use. The medication must be discontinued immediately if pregnancy is detected. ACOG and dermatology guidelines universally recommend against any retinoid use during pregnancy.

BreastfeedingAVOID

Tazarotene and breastfeeding

Not Recommended

Tazarotene is a potent prescription retinoid that is lipophilic (fat-soluble) and can be systemically absorbed from topical application. While specific data on excretion into breast milk is limited, vitamin A derivatives are fat-soluble and are known to pass into breast milk. The AAD and most dermatologists recommend avoiding tazarotene during breastfeeding due to potential infant exposure to vitamin A derivatives through breast milk. Infants are particularly vulnerable to vitamin A toxicity, which can affect liver function, bone development, and cause other serious adverse effects. While topical absorption results in lower systemic levels than oral retinoids, the potential risk to a breastfed infant outweighs cosmetic benefits. The manufacturer's labeling states that it is not known whether tazarotene is excreted in breast milk, but recommends caution when prescribing to breastfeeding mothers. Most dermatologists advise postponing tazarotene use until after weaning, especially since safer alternatives exist for treating acne and aging concerns during breastfeeding.

PostpartumSAFE

Tazarotene and postpartum

Safe to Use

For postpartum women not breastfeeding, tazarotene can be an effective treatment for melasma, acne, and skin texture concerns that may have developed or worsened during pregnancy. The medication is particularly useful for stubborn pregnancy-related pigmentation when combined with proper sun protection. The main considerations are the same as for any user: significant irritation potential and photosensitivity. Postpartum skin may be more sensitive due to hormonal changes, so a gradual introduction is essential. Women should ensure they are using effective contraception if sexually active, as tazarotene must be discontinued if another pregnancy occurs. The medication requires strict sun protection to prevent worsening of pigmentation and photodamage.

Trying to ConceiveAVOID

Tazarotene and trying to conceive

Not Recommended

Women trying to conceive should discontinue tazarotene before attempting pregnancy. The medication is a Category X drug with proven teratogenic effects. While most sources recommend stopping at least one month before conception attempts, some conservative recommendations suggest discontinuing three months prior to allow complete elimination. The concern with using retinoids while trying to conceive is the risk of early pregnancy exposure before a woman knows she is pregnant. Critical fetal development occurs in the first weeks after conception, during which time retinoid exposure can cause severe birth defects. Since tazarotene has documented risks and many couples take several months to conceive, the safest approach is complete avoidance during the TTC period.

PCOSSAFE

Tazarotene and PCOS

Safe to Use

Tazarotene is an effective prescription treatment for acne associated with PCOS. It addresses multiple factors in acne development including abnormal follicular keratinization, inflammation, and comedone formation. The medication can be particularly beneficial for persistent or treatment-resistant acne common in PCOS. For women with PCOS, tazarotene does not interact with hormonal aspects of the condition. It does not affect androgen levels, insulin sensitivity, or ovulation. The medication works through retinoid receptors in skin cells rather than systemic hormonal pathways. Women with PCOS who experience hormonal acne may find tazarotene helpful as part of a comprehensive treatment approach. Important considerations include the need for effective contraception during use, as pregnancy must be avoided while using any retinoid. Women with PCOS who are trying to conceive should not use tazarotene. The medication commonly causes significant irritation, so it should be introduced gradually, especially in combination with other acne treatments. Strict sun protection is essential as the medication increases photosensitivity.

General UseCAUTION

Tazarotene and general use

Caution Advised

For the general population, tazarotene is an effective prescription retinoid for treating acne, psoriasis, and photoaging. It is more potent than over-the-counter retinoids like retinol, providing faster results but also more significant side effects. The medication requires careful patient selection and monitoring. The most common concerns are severe skin irritation, including redness, peeling, burning, and dryness. Tazarotene causes more irritation than tretinoin or adapalene, requiring gradual introduction and often combination with moisturizers. The medication significantly increases photosensitivity, making strict sun protection mandatory. Contact with eyes, lips, and mucous membranes should be avoided. The FDA has approved tazarotene for specific indications, and it is available only by prescription. Women of childbearing age must use effective contraception and have negative pregnancy tests before and during treatment. The medication is not suitable for everyone and requires medical supervision. Alternatives like adapalene or tretinoin may be better tolerated while still providing retinoid benefits.

Same profiles

Everything else flagged for the same profiles

Keep reading

Related ingredients

Ingredients suggested in place of Tazarotene, each one with its own page here.

Ingredients that raise the same concerns.

Provenance

Where this came from

Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.

Assessment last pulled from the ingredient database on .

One ingredient is the easy case.

A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.

Download on theApp Store